Check out this easy online quiz to find out your Healthy Aging Score. It includes several of these values discussed above: https://drashori.com/healthy-aging-score/
Really appreciated this framework because it respects two realities at once: (1) most people are overwhelmed by “everything panels,” and (2) a small set of repeatable markers can catch drifting physiology early enough to change the curve. Your inclusion criteria (actionable, affordable, outcome-relevant, trackable) is exactly how clinicians should think about screening. 
A few things you did especially well:
1. BP as a personal-risk target, not a universal number. That’s a clinically mature point; “<120/80 for everyone” can be great for some and destabilizing for others, depending on age, comorbidity, and symptoms. 
2. Fasting glucose + insulin (HOMA-IR) as an early metabolic signal is so much more useful than waiting for A1c to drift. I also like that you connect this to practical levers (sleep/stress, training zone, body composition). 
3. ApoB as the “athero-particle” metric is an important upgrade from the default lipid panel for many patients; simple, interpretable, and directly tied to atherosclerotic burden. 
4. And I love the inclusion of waist-to-height ratio; a free, at-home proxy for visceral adiposity that patients can actually own. 
The closing metaphor (“don’t try to catch a falling vase”) is the real medicine here: we don’t need more fear-driven testing; we need earlier, calmer feedback loops that make prevention feel doable!
Check out this easy online quiz to find out your Healthy Aging Score. It includes several of these values discussed above: https://drashori.com/healthy-aging-score/
Fantastic health advise, thank you Dr Ashori!
Really appreciated this framework because it respects two realities at once: (1) most people are overwhelmed by “everything panels,” and (2) a small set of repeatable markers can catch drifting physiology early enough to change the curve. Your inclusion criteria (actionable, affordable, outcome-relevant, trackable) is exactly how clinicians should think about screening. 
A few things you did especially well:
1. BP as a personal-risk target, not a universal number. That’s a clinically mature point; “<120/80 for everyone” can be great for some and destabilizing for others, depending on age, comorbidity, and symptoms. 
2. Fasting glucose + insulin (HOMA-IR) as an early metabolic signal is so much more useful than waiting for A1c to drift. I also like that you connect this to practical levers (sleep/stress, training zone, body composition). 
3. ApoB as the “athero-particle” metric is an important upgrade from the default lipid panel for many patients; simple, interpretable, and directly tied to atherosclerotic burden. 
4. And I love the inclusion of waist-to-height ratio; a free, at-home proxy for visceral adiposity that patients can actually own. 
The closing metaphor (“don’t try to catch a falling vase”) is the real medicine here: we don’t need more fear-driven testing; we need earlier, calmer feedback loops that make prevention feel doable!